Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors

Telix Pharmaceuticals Limited American Depositary Shares logo
$16.20 -0.46 (-2.76%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$17.17 +0.97 (+5.98%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TLX vs. TEVA, SMMT, ITCI, GMAB, RDY, VTRS, MRNA, QGEN, ASND, and ROIV

Should you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Moderna (MRNA), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry.

Telix Pharmaceuticals Limited American Depositary Shares vs.

Teva Pharmaceutical Industries (NYSE:TEVA) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership.

Telix Pharmaceuticals Limited American Depositary Shares has lower revenue, but higher earnings than Teva Pharmaceutical Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teva Pharmaceutical Industries$16.62B1.16-$1.64B-$1.15-14.73
Telix Pharmaceuticals Limited American Depositary Shares$783.21M6.99N/AN/AN/A

Teva Pharmaceutical Industries received 1335 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 67.90% of users gave Teva Pharmaceutical Industries an outperform vote.

CompanyUnderperformOutperform
Teva Pharmaceutical IndustriesOutperform Votes
1339
67.90%
Underperform Votes
633
32.10%
Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes
4
100.00%
Underperform Votes
No Votes

In the previous week, Teva Pharmaceutical Industries had 24 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 24 mentions for Teva Pharmaceutical Industries and 0 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Teva Pharmaceutical Industries' average media sentiment score of 0.99 beat Telix Pharmaceuticals Limited American Depositary Shares' score of 0.00 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media.

Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.

Company Net Margins Return on Equity Return on Assets
Teva Pharmaceutical Industries-9.91% 42.46% 6.65%
Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A

54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Teva Pharmaceutical Industries presently has a consensus price target of $24.43, suggesting a potential upside of 44.21%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus price target of $22.00, suggesting a potential upside of 35.80%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teva Pharmaceutical Industries
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
Telix Pharmaceuticals Limited American Depositary Shares
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Teva Pharmaceutical Industries beats Telix Pharmaceuticals Limited American Depositary Shares on 12 of the 15 factors compared between the two stocks.

Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLX vs. The Competition

MetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$5.47B$6.47B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.10%
P/E RatioN/A9.0626.7519.70
Price / Sales6.99259.83392.41121.79
Price / CashN/A65.8538.2534.62
Price / BookN/A6.456.774.50
Net IncomeN/A$143.98M$3.23B$248.22M
7 Day Performance-2.88%0.38%0.43%-0.80%
1 Month Performance-11.48%2.14%9.07%11.52%
1 Year PerformanceN/A-0.33%18.59%8.99%

Telix Pharmaceuticals Limited American Depositary Shares Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLX
Telix Pharmaceuticals Limited American Depositary Shares
N/A$16.20
-2.8%
$22.00
+35.8%
N/A$5.47B$783.21M0.00N/AGap Down
TEVA
Teva Pharmaceutical Industries
3.2803 of 5 stars
$17.92
+5.8%
$24.43
+36.4%
+0.3%$20.31B$16.62B-12.3636,800Analyst Upgrade
Options Volume
SMMT
Summit Therapeutics
3.0102 of 5 stars
$25.26
+5.4%
$37.40
+48.1%
+487.0%$18.76B$700,000.00-90.21110Positive News
ITCI
Intra-Cellular Therapies
0.8592 of 5 stars
$131.87
flat
$109.70
-16.8%
N/A$14.05B$680.50M-151.57560News Coverage
GMAB
Genmab A/S
3.4387 of 5 stars
$19.93
+2.9%
$39.17
+96.5%
-29.5%$12.78B$21.64B11.451,660News Coverage
Positive News
High Trading Volume
RDY
Dr. Reddy's Laboratories
2.3076 of 5 stars
$13.93
+3.9%
$17.00
+22.1%
+2.5%$11.62B$311.31B22.1724,800Positive News
Gap Up
VTRS
Viatris
1.8923 of 5 stars
$8.96
+2.2%
$10.50
+17.2%
-21.8%$10.63B$14.33B-12.1137,000Trending News
MRNA
Moderna
4.4457 of 5 stars
$25.70
+6.0%
$53.95
+109.9%
-83.6%$9.94B$3.14B-2.773,900Trending News
Analyst Forecast
QGEN
Qiagen
3.9764 of 5 stars
$42.92
+2.5%
$48.42
+12.8%
+0.1%$9.54B$1.98B119.526,030Positive News
ASND
Ascendis Pharma A/S
3.376 of 5 stars
$154.43
+2.1%
$216.07
+39.9%
+22.0%$9.42B$368.70M-21.75640Positive News
ROIV
Roivant Sciences
2.1115 of 5 stars
$10.99
+3.3%
$17.50
+59.2%
-3.1%$7.84B$122.59M-73.26860Positive News
Upcoming Earnings
Insider Trade

Related Companies and Tools


This page (NASDAQ:TLX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners